An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines

Clicks: 469
ID: 118352
1994
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #1 of 24 articles by views in virus research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
RSV and PIV3 are responsible for about 30% of severe viral respiratory tract disease leading to hospitalization of infants and children. For this reason, there is a need to develop vaccines effective against these viruses. Since these viruses cause severe disease in early infancy, vaccines must be e …
Reference Key
br1994virusan Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Murphy BR;Hall SL;Kulkarni AB;Crowe JE;Collins PL;Connors M;Karron RA;Chanock RM;;
Journal virus research
Year 1994
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8030364
Keywords
vaccination immunity National Center for Biotechnology Information NCBI NLM MEDLINE Mice review animals clinical trials as topic humans pubmed abstract nih national institutes of health national library of medicine adult Infant newborn Antibodies respiratory syncytial viruses / immunology* sigmodontinae vaccines r m chanock b r murphy viral / biosynthesis viral / immunology human / immunology* influenza human / prevention & control respiratory syncytial virus infections / prevention & control maternally-acquired attenuated parainfluenza virus 3 anti-idiotypic / immunology pan troglodytes pmid:8030364 doi:10.1016/0168-1702(94)90059-0 s l hall iscoms influenza vaccines* / immunology influenza vaccines* / toxicity peptide fragments / chemical synthesis peptide fragments / immunology synthetic viral vaccines* / immunology viral vaccines* / toxicity

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.